Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug ... - MarketWatch (press release)
MarketWatch (press release) "Our plan is to pursue approval of peginesatide for the treatment of anemia in CRF patients on dialysis," said Arlene M. Morris, chief executive officer of